alexa Pharmacogenetics: Advanced Drug Administration
ISSN: 1747-0862

Journal of Molecular and Genetic Medicine
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

9th International Conference on Genomics & Pharmacogenomics
June 15-16, 2017 London, UK

Rozana Oliveira Goncalves
Oswaldo Cruz Foundation (Fiocruz), Brazil
ScientificTracks Abstracts: J Mol Genet Med
DOI: 10.4172/1747-0862-C1-015
Adverse drug reactions are influenced by multiple factors, including health, environmental influences and genetic characteristics. Pharmacogenetics studies how inter-individual genetic variations may affect drug responses. It is the technology that researches the influence of genetic variation on drug response in patients by correlating gene expression or polymorphisms with a drug's efficacy or toxicity. It is well known that Adverse Drug Reactions (ADRs) are a relevant health matter, being the fourth cause of demise in hospitalized patients. Important drug agencies have demonstrated a great interest in the early detection of ADRs due to their high incidence and increasing health care costs. Pharmacogenetics aims to develop the means to optimize drug therapy with respect to the patients’ genotype, to ensure maximum efficacy with minimal adverse effects. Pharmacogenetics is a research field still in development and therapy individualization remain a challenge for the future. It is important to appreciate that many genes may influence the response to drugs, and the genetic polymorphisms present ethnic variation, which complicates the identification of genetic variations which are most relevant. Clinical validation of genetic markers of the greatest clinical relevance is perhaps one of the major limiting factors in the use of genetic information when making treatment decisions.

Rozana Oliveira Goncalves is currently a Biology Teacher in the city of Salvador in Brazil. In 1997, she completed a course in Biological Sciences at Catholic University of Salvador. In 2001, she began her career in research as an intern in the Laboratory of Human Genetics and at Maternidade Climério de Oliveira. In 2006, she started her Master's degree in Biotechnology and Investigative Medicine at Gonçalo Muniz Research Center/Fiocruz. She has experience in Genetics, working mainly in the following subjects: Occupational exposure, bio-indicators, exchanges between chromatid sisters, and recurrent abortion.

Email: [email protected]

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version